Pharming Group NV (PHARM)-Financial and Strategic SWOT Analysis Review

Pharming Group NV (PHARM)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH7257FSA
  • |
  • Pages: 53
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharming Group NV (PHARM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company's flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with hereditary angioedema (HAE). Its product pipeline consists recombinant human C1 inhibitor (rhC1INH) for the treatment of delayed graft function; and recombinant human factor VIII (rhFactor VIII) for the treatment of haemophilia A. The company has manufacturing facilities in the Netherlands and the US. It markets and sells its products worldwide through distributors and partners. Pharming is headquartered in Leiden, the Netherlands.

Pharming Group NV Key Recent Developments

May 17,2017: Pharming Group Interim Report on Financial Results for the First Quarter 2017

Mar 09,2017: Pharming Group: Report on Preliminary Financial Results for 2016

Oct 27,2016: Pharming Reports on Financial Results for the First Nine Months of 2016

Oct 03,2016: Pharming Reports on Financial Results for the First Eight Months of 2016

Jul 28,2016: Pharming Reports on Financial Results for the First Six Months of 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Pharming Group NV-Key Facts 5

Pharming Group NV-Key Employees 6

Pharming Group NV-Key Employee Biographies 7

Pharming Group NV-Major Products and Services 8

Pharming Group NV-History 9

Pharming Group NV-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Pharming Group NV-Business Description 13

Pharming Group NV-Corporate Strategy 14

Pharming Group NV-SWOT Analysis 15

SWOT Analysis-Overview 15

Pharming Group NV-Strengths 15

Pharming Group NV-Weaknesses 16

Pharming Group NV-Opportunities 17

Pharming Group NV-Threats 18

Pharming Group NV-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Pharming Group NV, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

May 17, 2017: Pharming Group Interim Report on Financial Results for the First Quarter 2017 30

Mar 09, 2017: Pharming Group: Report on Preliminary Financial Results for 2016 32

Oct 27, 2016: Pharming Reports on Financial Results for the First Nine Months of 2016 34

Oct 03, 2016: Pharming Reports on Financial Results for the First Eight Months of 2016 38

Jul 28, 2016: Pharming Reports on Financial Results for the First Six Months of 2016 41

Jul 28, 2016: Ruconest sales up in second quarter 44

May 18, 2016: Pharming Group Interim report on Financial Results for Q1 2016 45

Mar 10, 2016: Pharming Group Report on Preliminary Financial Results 2015 48

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53

List of Figures

Pharming Group NV, Performance Chart (2012-2016) 24

Pharming Group NV, Ratio Charts 26

Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Pharming Group NV, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

List of Tables

Pharming Group NV, Key Facts 5

Pharming Group NV, Key Employees 6

Pharming Group NV, Key Employee Biographies 7

Pharming Group NV, Major Products and Services 8

Pharming Group NV, History 9

Pharming Group NV, Subsidiaries 12

Pharming Group NV, Key Competitors 19

Pharming Group NV, Ratios based on current share price 20

Pharming Group NV, Annual Ratios 21

Pharming Group NV, Annual Ratios (Cont...1) 22

Pharming Group NV, Annual Ratios (Cont...2) 23

Pharming Group NV, Interim Ratios 25

Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Pharming Group NV, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Pharming Group NV, Recent Deals Summary 29

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pharming Group NV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com